Immuron Limited (IMRN)
NASDAQ: IMRN · IEX Real-Time Price · USD
2.161
-0.019 (-0.87%)
Jul 2, 2024, 3:52 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $12.32 million as of July 2, 2024. Its market cap has increased by 9.01% in one year.
Market Cap
12.32M
Enterprise Value
1.37M
1-Year Change
9.01%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $12.32M, a decrease of -56.17%. That is a compound annual growth rate of -11.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 12.30M | 14.95% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Star Equity Holdings | 14.39M |
| Mustang Bio | 14.39M |
| Novo Integrated Sciences | 14.29M |
| Cara Therapeutics | 14.11M |
| Psychemedics | 14.05M |
| Edesa Biotech | 13.76M |
| Aptose Biosciences | 13.75M |
| BioRestorative Therapies | 13.74M |